Description
An alkaloid that irreversibly inhibits both human VMAT1 and VMAT2 (Ki = 34 and 12 nM, respectively); used to experimentally deplete monoamines in animals; also inhibits P-glycoprotein (IC50 = 0.5 µM)
Formal name: (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester
Synonyms: NSC 237659|NSC 59272|Rausedil
Molecular weight: 608.7
CAS: 50-55-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Alkaloids||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Neuroscience